Thomas W. Flaig

A Phase II Trial Using Grape Seed Extract for Prostate Cancer Patients With Nonmetastatic Prostate‐Specific Antigen Progression After Local Therapy

ABSTRACT Prostate cancer (PCa) is a major cause of cancer‐related death among American men. While androgen deprivation therapy (ADT) is commonly used in the treatment of rising prostate‐specific antigen (PSA) levels after primary therapy, its adverse systemic side effects support...